Satellos Bioscience Announces Q2 2023 Financial Results and Operational Highlights - Yahoo Finance

CBDX Stock  USD 0.0001  0.00  0.00%   
Slightly above 56% of Curative Biosciences' investor base is looking to short. The analysis of overall sentiment of trading Curative Biosciences pink sheet suggests that many investors are alarmed at this time. Curative Biosciences' investing sentiment can be driven by a variety of factors including economic data, Curative Biosciences' earnings reports, geopolitical events, and overall market trends.
  
Satellos Bioscience Announces Q2 2023 Financial Results and Operational Highlights Yahoo Finance

Read at news.google.com
Google News at Macroaxis
  

Curative Biosciences Fundamental Analysis

We analyze Curative Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Curative Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Curative Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Probability Of Bankruptcy

Probability Of Bankruptcy Comparative Analysis

Curative Biosciences is currently under evaluation in probability of bankruptcy category among its peers. Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Peers

Trending Equities

BBY  2.08   
0%
100.0%
TGT  1.71   
0%
82.0%
INTC  1.69   
0%
81.0%
AA  1.20   
0%
57.0%
AAPL  1.02   
0%
49.0%
C  1.01   
0%
48.0%
HD  0.45   
0%
21.0%
IBM  0.22   
0%
10.0%
UPS  0.03   
0%
1.0%
MET  0.02   
1.0%
0%
CVX  0.11   
5.0%
0%
CVS  0.18   
8.0%
0%
S  0.46   
22.0%
0%
T  0.47   
22.0%
0%
AAL  0.82   
39.0%
0%
WFC  1.35   
64.0%
0%

Additional Tools for Curative Pink Sheet Analysis

When running Curative Biosciences' price analysis, check to measure Curative Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Curative Biosciences is operating at the current time. Most of Curative Biosciences' value examination focuses on studying past and present price action to predict the probability of Curative Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Curative Biosciences' price. Additionally, you may evaluate how the addition of Curative Biosciences to your portfolios can decrease your overall portfolio volatility.